文献速递肥胖与代谢综合征糖尿病

Ghrelin抑制TNF-α诱导的人肝细胞凋亡、自噬与焦亡:在肥胖相关NAFLD中的作用

Ghrelin Reduces TNF-α-Induced Human Hepatocyte Apoptosis, Autophagy, and Pyroptosis: Role in Obesity-Associated NAFLD.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

研究在158名参与者中测定血浆Ghrelin亚型与TNF-α,并在76名接受减重手术的肥胖患者肝活检中评估肝细胞死亡。肥胖合并NAFLD患者循环TNF-α及酰基化/去酰基化Ghrelin比值升高、去酰基化Ghrelin降低;减重术后6个月该比值下降且肝功能改善。体外HepG2细胞中酰基化与去酰基化Ghrelin均减少TNF-α诱导的凋亡与焦亡,酰基化Ghrelin还抑制自噬。

要点

  • 肥胖合并NAFLD患者循环TNF-α及酰基化/去酰基化Ghrelin比值升高,去酰基化Ghrelin降低。
  • 减重术后6个月酰基化/去酰基化Ghrelin水平下降,肝功能改善。
  • 体外实验中酰基化与去酰基化Ghrelin减少TNF-α诱导的HepG2细胞凋亡与焦亡。

核心结论

  • Ghrelin是肝细胞死亡的保护因素。
  • 肥胖合并NAFLD患者酰基化/去酰基化Ghrelin比值升高可能是克服TNF-α诱导肝细胞凋亡、自噬与焦亡的代偿机制。

研究设计与样本

  • 在158名参与者中测定血浆Ghrelin亚型与TNF-α。
  • 在有肝脏超声和病理分析的76名接受减重手术的重度肥胖患者肝活检中评估肝细胞死亡。
  • 体外用人HepG2肝细胞测定酰基化与去酰基化Ghrelin对基础及TNF-α诱导细胞死亡的作用。

主要发现

  • 肥胖合并NAFLD患者循环TNF-α及酰基化/去酰基化Ghrelin比值升高,去酰基化Ghrelin水平降低。
  • 减重术后6个月酰基化/去酰基化Ghrelin水平下降,肝功能改善。
  • 肥胖合并2型糖尿病患者肝脏Ghrelin O-酰基转移酶转录本增加,肝脏凋亡、焦亡增加且自噬受损。
  • HepG2细胞中酰基化与去酰基化Ghrelin处理减少TNF-α诱导的凋亡,表现为caspase-8和caspase-3裂解减少及TUNEL阳性细胞减少。
  • 酰基化与去酰基化Ghrelin减少TNF-α诱导的焦亡,表现为caspase-1活化降低和高迁移率族蛋白B1表达降低。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Human obesity is associated with increased circulating TNF-α, a proinflammatory cytokine that induces hepatocyte cell death. OBJECTIVE: The potential beneficial effects of acylated and desacyl ghrelin in the progression of nonalcoholic fatty liver disease (NAFLD) to nonalcoholic steatohepatitis in obesity via the inhibition of TNF-α-induced hepatocyte apoptosis, autophagic cell death, and pyroptosis were investigated. DESIGN, SETTINGS, AND PARTICIPANTS: Plasma ghrelin isoforms and TNF-α were measured in 158 participants, and hepatocyte cell death was evaluated in liver biopsies from 76 patients with morbid obesity undergoing bariatric surgery with available liver echography and pathology analysis. The effect of acylated and desacyl ghrelin on basal and TNF-α-induced cell death was determined in vitro in human HepG2 hepatocytes. RESULTS: Circulating TNF-α and the acylated/desacyl ghrelin ratio were increased, whereas desacyl ghrelin levels were decreased in patients with obesity and NAFLD. Six months after bariatric surgery, decreased acylated/desacyl ghrelin levels, and improved hepatic function were found. Patients with obesity and type 2 diabetes showed increased hepatic ghrelin O-acyltransferase transcripts as well as an increased hepatic apoptosis, pyroptosis, and compromised autophagy. In HepG2 hepatocytes, acylated and desacyl ghrelin treatment reduced TNF-α-induced apoptosis, evidenced by lower caspase-8 and caspase-3 cleavage, as well as TUNEL-positive cells and pyroptosis, revealed by decreased caspase-1 activation and lower high-mobility group box 1 expression. Moreover, acylated ghrelin suppressed TNF-α-activated hepatocyte autophagy, as evidenced by a decreased LC3B-II/I ratio and increased p62 accumulation via AMPK/mTOR. CONCLUSIONS: Ghrelin constitutes a protective factor against hepatocyte cell death. The increased acylated/desacyl ghrelin ratio in patients with obesity and NAFLD might constitute a compensatory mechanism to overcome TNF-α-induced hepatocyte apoptosis, autophagy, and pyroptosis.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ezquerro S, Mocha F, Frühbeck G, et al. Ghrelin Reduces TNF-α-Induced Human Hepatocyte Apoptosis, Autophagy, and Pyroptosis: Role in Obesity-Associated NAFLD. J Clin Endocrinol Metab. 2019. PMID: 30137403. doi:10.1210/jc.2018-01171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。